Approved Oncology Targeting Small Molecule Kinase Inhibitors
First cancer targeting tyrosine kinase inhibitor imatinib was approved to enter the market by the US Food and Drug Administration ...
First cancer targeting tyrosine kinase inhibitor imatinib was approved to enter the market by the US Food and Drug Administration ...
Developed by OmicsX. The entirety of this site is protected by copyright © 2025 HH BioTechnologies Private Ltd.
Developed by OmicsX. The entirety of this site is protected by copyright © 2025 HH BioTechnologies Private Ltd.